MedTrace Logo

Effects of Melatonin in Untreated Obstructive Sleep Apnea

NCT03492736 · Status: TERMINATED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2019-01-31

No results posted yet for this study

Summary

The investigators have previously shown that 1 week of 10mg Melatonin improves sleep consolidation in untreated obstructive sleep apnea (OSA) patients. This study aims to extend on those findings to determine if longer treatment of Melatonin improves other outcomes in untreated OSA patients.

Conditions

Interventions

DIETARY_SUPPLEMENT

Melatonin

30 days 10mg Melatonin taken nightly 1 hour before bed

OTHER

Placebo

30 days placebo taken nightly 1 hour before bed

Sponsors & Collaborators

  • Naomi Deacon

    lead OTHER

Principal Investigators

  • Naomi L Deacon, Ph.D. · UCSD Pulmonary and Sleep Medicine

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2018-10-01
Completion
2018-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03492736 on ClinicalTrials.gov